LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1
Related Experiment Video
Updated: Jan 22, 2026

Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence
Published on: November 5, 2021
Bolun Ai1, Xiangyi Kong1, Xiangyu Wang1
1Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Abstract:
Previously, several protein-coding tumor suppressors localized at 1p36 have been reported. In the present work, we focus on functional long non-coding RNAs (lncRNAs) embedded in this locus. Small interfering RNA was used to identify lncRNA candidates with growth-suppressive activities in breast cancer. The mechanism involved was also explored. LINC01355 were downregulated in breast cancer cells relative to non-malignant breast epithelial cells. Overexpression of LINC01355 significantly inhibited proliferation, colony formation, and tumorigenesis of breast cancer cells. LINC01355 arrested breast cancer cells at the G0/G1 phase by repressing CCND1. Moreover, LINC01355 interacted with and stabilized FOXO3 protein, leading to transcriptional repression of CCND1. Importantly, LINC01355-mediated suppression of breast cancer growth was reversed by knockdown of FOXO3 or overexpression of CCND1. Clinically, LINC01355 was downregulated in breast cancer specimens and correlated with more aggressive features. There was a negative correlation between LINC01355 and CCND1 expression in breast cancer samples. LINC01355 acts as a tumor suppressor in breast cancer, which is ascribed to enhancement of FOXO3-mediated transcriptional repression of CCND1. Re-expression of LINC01355 may provide a potential therapeutic strategy to block breast cancer growth and progression.
Insights
Long non-coding RNA LINC01355 acts as a tumor suppressor in breast cancer by inhibiting cell growth and progression. Its re-expression may offer a new therapeutic strategy against breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The 1p36 chromosomal locus contains known tumor suppressor genes.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
- The function of lncRNAs at the 1p36 locus in breast cancer remains largely unexplored.
Purpose of the Study:
- To identify and characterize functional lncRNAs with tumor-suppressive activity in breast cancer.
- To elucidate the molecular mechanism underlying the function of identified lncRNAs.
- To evaluate the clinical relevance of these lncRNAs in breast cancer patients.
Main Methods:
- Small interfering RNA (siRNA) screening to identify growth-inhibitory lncRNAs.
- Overexpression and knockdown experiments in breast cancer cell lines.
- Cell cycle analysis, proliferation, colony formation, and tumorigenesis assays.
- Western blotting, qRT-PCR, and RNA immunoprecipitation (RIP) assays.
- Analysis of clinical breast cancer specimens.
Main Results:
- LINC01355 was identified as a downregulated lncRNA in breast cancer cells.
- Overexpression of LINC01355 inhibited breast cancer cell proliferation, colony formation, and tumorigenesis.
- LINC01355 induced G0/G1 cell cycle arrest by repressing CCND1 expression.
- LINC01355 stabilized FOXO3 protein, enhancing FOXO3-mediated transcriptional repression of CCND1.
- Downregulation of LINC01355 correlated with aggressive breast cancer features and poor prognosis.
Conclusions:
- LINC01355 functions as a tumor suppressor in breast cancer.
- The tumor-suppressive role of LINC01355 is mediated through the FOXO3/CCND1 pathway.
- LINC01355 represents a potential therapeutic target for breast cancer treatment.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Repressed Memory
Transcription Factors
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Transcription
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...

